MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.45 CNY | -1.40% |
|
-3.42% | -0.73% |
| May. 24 | Mabwell Announces 9MW2821 Clinical Data | CI |
| May. 07 | Mabwell Announces FDA Grants Orphan Drug Designation to 9MW2821 | CI |
Evolution of the average Target Price on Mabwell (Shanghai) Bioscience Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
b.IF_IXufm2SLgg-By62pFAnZzRgMV0wG4726azITGDrc.aTigGJeg6hLY1pU9mhk1NQYhdmlQmGrIhSTNh8CBfNxTD6UWvrnvD5DFoQ~3f00c7afa114815709575abee7a2f810
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
32.45
CNY
Average target price
48
CNY
Spread / Average Target
+47.92%
High Price Target
48
CNY
Spread / Highest target
+47.92%
Low Price Target
48
CNY
Spread / Lowest Target
+47.92%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688062 Stock
- Consensus Mabwell (Shanghai) Bioscience Co., Ltd.
